Severe Preeclampsia

measurement of serum free and total testosterone

serum androgen levels

Ain Shams University

AinShams University

Serum Androgen Levels as a Marker for the Severity of Preeclampsia

assess if serum androgen levels could be used as a marker for the severity of preclampsia

serum androgen levels as marker for the severity of preeclampsia

Joseph Adel Ibrahiem Johny

Principal Investigator

A prospective study that will evaluate all pregnant women admitted for clinical treatment and / or surgery through the application of a thromboprophylaxis protocol with risk assessment score.The patient in whom prophylaxis would be indicated are those with scores greater than or equal to 3. The drug to be used is enoxaparin and the dose to be used depends on the weight of the patient.It will be further assessed: adverse effects of treatment with enoxaparin, protocol failure in the group treated and untreated (without anticoagulation) and bleeding incidence in both groups.

Pregnant women admitted in hospital for clinical treatment and/or delivery and that does not score for thromboprophylaxis.

Thrombophilia Associated With Pregnancy

Perioperative/Postoperative Complications

Venous Thrombosis

Pulmonary Embolism

Other Specified Risk Factors in Pregnancy

Deep Vein Thrombosis

Patients who score higher or equal to 3, receive a prophylactic dose of enoxaparin. The first dose of enoxaparin is administered 8 hours after vaginal or abdominal delivery. Subsequent doses are administered daily for up to 15 days. The dose depends on patient weight.

Enoxaparin

Hospitalized patients that score less than three are not prescribed enoxaparin.

No intervention

University of Sao Paulo General Hospital

Thromboprophylaxis in Pregnant Women in Hospital: A Prospective Clinical Trial

Identify early risk factors for VTE in hospitalized pregnant women and prescribe appropriate prophylaxis to reduce the incidence, morbidity and mortality of VTE. The patients that score ≥ 3 will receive enoxaparin. This group will be analyzed for the incidence of adverse outcomes: VTE, bleeding, death until 3 months post hospitalization. This same analysis will be done in those patients who have not received heparin. The patients that could not receive heparin due to bleeding risk will be analyzed also. The analysis of the score will also describe if the higher the score, the higher the index of adverse events, mainly when it is not possible to prescribe the prophylaxis.

VENINA ISABEL POÇO VIANA LEME DE BARROS

MD, PhD, Group of Thrombosis and Thrombophilia in pregnancy, Clinics Hospital, University of Sao Paulo

Inpatients and outpatients followed at Instituto de Psiquiatria da Universidade Federal do Rio de Janeiro, Brazil

Insulin Resistance

Thrombophilia

Psychosis

Institudo de Psiquiatria da UFRJ

Prevalence of Clinical and Laboratory Markers of Hypofibrinolysis in Psychotic Patients

The investigators' hypothesis is that a high prevalence of hypofibrinolysis markers will be probably found in psychotic patients.

The investigators are assessing clinical and laboratory markers of plasminogen activator imbalance in psychiatric patients who require electroconvulsive therapy, specifically patients with major depressive disorders and schizophrenia.

protein s deficiency/fetma

Serum Androgen Levels as a Marker for the Severity of Preeclampsia

Thromboprophylaxis in Pregnant Women in Hospital: A Prospective Clinical Trial

Prevalence of Clinical and Laboratory Markers of Hypofibrinolysis in Psychotic Patients

Den mest kompletta databasen med medicinska örter som stöds av vetenskapen